Trademark: VACCINE
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for VACCINE
We do not have any records of a proof of use for VACCINE at this moment.
Possible trademark infringements of VACCINE
Basic Information about VACCINE
- Serial Number
- 86730188
- Filing Date
- 19 Aug 2015
- Registration Number
- 5076290
- Registration Date
- 08 Nov 2016
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of VACCINE on the blockchain with WikiTrademarks.io.
- First use of VACCINE anywhere
- VACCINE was first used on 11 May 2016 for the primary classification of goods and services, international, 003 (Cosmetics and cleaning preparations)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 2
- International Code
- 003
- US Codes
- 001; 004; 006; 050; 051; 052
Who owns VACCINE?
1. Deciem Beauty Group Inc. Toronto, Ontario
2. Deciem Beauty Group Inc. Toronto, Ontario
3. Deciem Beauty Group Inc. Toronto, Ontario
Correspondent
- Douglas R. Wolf
- Wolf, Greenfield & Sacks, P.C.
- 600 Atlantic Avenue
- Boston MA 02210
Recent News about VACCINE
Other Barks & Bites for Friday, October 18: OpenAI Outlines Defensive Patent Strategy; Microsoft Files Opposition in Lawsuit Alleging Illegal Buyer’s Cartel for Patent Licenses; Moderna Under Fire for Spikevax Vaccine Tech Tweet this
This week on MIP: Fresh UPC decision, COVID vaccine sharing Tweet this
Other Barks & Bites for Friday, August 4: Ted Cruz Proposes Bill to Clarify NCCA NIL Rules; GSK Accuses Pfizer of Infringing on its RSV Vaccine Patent; American Axle Claim Upheld in District Court Tweet this
Other Barks & Bites for Friday, June 9: CAFC Issues Precedential Opinion on Inventorship, USPTO Releases Five-Year Plan, Vaccine Makers Get Hit with Another Patent Infringement Suit Tweet this
Other Barks & Bites for Friday, March 24: Non-DOCX Fee Delayed Further; SCOTUS Petition Says Hirshfeld’s Review of PTAB Decision Violated Federal Vacancies Reform Act; Moderna CEO Grilled by Senate Committee over COVID Vaccine Price Hike Tweet this
Other Barks & Bites for Friday, November 4: CAFC Offers Mixed Bag in Uniloc Appeals, Global Music Copyright Market Valued at Nearly $40 Billion, and Moderna Loses Bid to Have U.S. Government Face Vaccine Patent Claims Tweet this
BIO and Vaccine Manufacturers Group Sign on to Berlin Declaration on Vaccine Access Tweet this
Other Barks and Bites for Friday, October 21: Senators Push Biden to Protect Vaccine IP, Thaler Shot Down Again at CAFC and UPC Confirms 85 Judges Tweet this
Moderna sues Pfizer, BioNTech over COVID-19 mRNA Vaccine Patents Tweet this
Senators Call for Transparency as Global Leaders Call for Action on COVID Vaccine Waiver Talks Tweet this
This week in IP: vaccine waiver compromise agreed, IP intensive industries make 41% US GDP, and more Tweet this
Latest WTO Waiver Compromise Text Targets COVID Vaccine Patents, Draws Criticism from Both Sides Tweet this
SCOTUS, Vaccine Mandates and Patent Law: God Help Us Tweet this
Examining the Moderna-NIH COVID-19 Vaccine Debate in the Context of Bayh-Dole Tweet this
FDA Resists FOIA Request for Vaccine Approval Info as Biden Administration Offers to Share it with the World Tweet this
Black market for fake vaccine cards thrives on Telegram Tweet this
Black market for fake vaccine cards thrives on Telegram Tweet this
Apple Partners TSMC and Foxconn are Scrambling to Find COVID-19 Vaccine Sources and Supply to keep Production Humming Tweet this
Other Barks & Bites for Friday, June 4: EU Plans Alternative to Vaccine Patent Waiver Proposal, CAFC Finds Prosecution Laches as Section 145 Defense for USPTO, and Antitrust Investigations into Facebook Marketplace Launched in EU and UK Tweet this
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io